Exepress Shunt Implantation In Patients With Chronic Angle Closure Glaucoma
Published 2022 - 40th Congress of the ESCRS
Reference: PP15.05 | Type: Free paper | DOI: 10.82333/mhx7-ne32
Authors: Ahmed Samir* 1 , mohamed aldamasy 1
1opthalmology,zagazig hospital,zagazig,Egypt
Purpose
to evaluate the role of automated peripheral iridectomy as adjunctive tool combined with phacoemulsification and ExPress shunt implantation in management of cases with chronic angel closure glaucoma
Setting
magrabi eye hospital
Methods
This prospective study included 22 eyes of 22 patients with chronic angle closure glaucoma and
cataract who underwent Ex-PRESS shunt implantation, cataract extraction and surgical
peripheral iridectomy at the site of shunt implantation in the period between January 2018 and
April 2020. The model used in this study was P50 (Ex-PRESS P50, Alcon Laboratories, Fort
Worth, Texas, USA).
cataract who underwent Ex-PRESS shunt implantation, cataract extraction and surgical
peripheral iridectomy at the site of shunt implantation in the period between January 2018 and
April 2020. The model used in this study was P50 (Ex-PRESS P50, Alcon Laboratories, Fort
Worth, Texas, USA).
Results
After surgery, the mean IOP was 11.3±1.2 mmHg, 14.5 ±1.6 mmHg, 14.8±2.1 mmHg, 15.3±1.9
mmHg and 17.4±1.8 mmHg at 7 days, 1 month, 3 months, 6 months and 12 months respectively.
All postoperative IOP was significantly lower compared with preoperative IOP (P = 0.001).
Figure-1
There was a significant decrease in the number of medications required after surgery. The
baseline mean number of medications was 3.4 ± 0.02 (range from 1 to 4), while post-operatively
the mean number of medications decreased to 0.7 ±0.01 at 12 months (P < 0.01).
The qualified success rate was (6/24 eyes), and the complete success rate was (18/22) at 12
months, respectively.
T
mmHg and 17.4±1.8 mmHg at 7 days, 1 month, 3 months, 6 months and 12 months respectively.
All postoperative IOP was significantly lower compared with preoperative IOP (P = 0.001).
Figure-1
There was a significant decrease in the number of medications required after surgery. The
baseline mean number of medications was 3.4 ± 0.02 (range from 1 to 4), while post-operatively
the mean number of medications decreased to 0.7 ±0.01 at 12 months (P < 0.01).
The qualified success rate was (6/24 eyes), and the complete success rate was (18/22) at 12
months, respectively.
T
Conclusions
the combined phacoemulsification and ExPress shunt implantation with automated peripheral iridectomy is an effective and safe procedure to treat chronic angel closure glaucoma